Researchers produce vaccines at Vaccine and Biological Production No.1 (VABIOTECH), one of the four companies that are studying COVID-19 vaccines.  Photo vietnamplus.vn

HÀ NỘI — The Ministry of Health is considering authorising first phase human trials of a COVID-19 vaccine by the end of this month.

The vaccine is produced by Nanogen Pharmaceutical Biotechnology JSC (Nanogen), one of the four companies that are studying COVID-19 vaccines. If the company’s vaccine is approved, it will be the country's first to reach the stage of human trials.

Nanogen plans to test the vaccine on 60 people in the first stage.

The second stage will see the participation of 400 people.

Previously, this vaccine has undergone many assessments. It has also been sent abroad for testing on primates to evaluate the safety and ability to produce immunity in animals.

Nguyễn Ngô Quang, Deputy Director of Department of Science, Technology and Training under the health ministry, said that after the vaccine was tested on animals, the ministry will provide maximum support for manufacturers to conduct human clinical trials. However, they must ensure safety for volunteers and ethical aspects of research.

Việt Nam has four manufactures who are researching and produced COVID-19 vaccines. They are Polyvac and the Institute of Vaccines and Medical Biologicals (Ivac), Vaccine and Biological Production No.1 (Vabiotech), and Center for Research and Production of Vaccines and Biologicals (Polyvac) and Nanogen.

Ivac is in the process of completing research protocols on clinical trials for the COVID-19 vaccine. It is expected that the company will submit the clinical trial documents by the end of this year.

Vabiotech has also started a pre-clinical trial of the COVID-19 vaccine in monkeys. After the shots are done, the monkeys will be monitored for about three months, then their blood samples will be collected for testing.

Earlier, the company tested the vaccine on mice. It is expected that Vabiotech will have the first batch of vaccines for clinical trials early next year.

As many as 187 companies around the world are developing COVID-19 vaccines, of which 38 are undergoing human trials. Nine products are in the third phase – testing on a large number of volunteers.

Việt Nam’s health ministry and scientists are hoping to have commercial products in the fourth quarter of next year.

The country has registered to receive priority access to a COVID-19 vaccine when it is available on the market. — VNS